AMETEK, Inc. (BIT:1AME)

Market Cap	36.59B
Revenue (ttm)	5.94B
Net Income (ttm)	1.22B
Shares Out	n/a
EPS (ttm)	5.29
PE Ratio	29.89
Forward PE	24.83
Dividend	0.87 (0.57%)
Ex-Dividend Date	Mar 14, 2025

Volume	n/a
Average Volume	0
Open	153.60
Previous Close	153.60
Day's Range	153.60 - 153.60
52-Week Range	153.60 - 157.82
Beta	n/a
RSI	n/a
Earnings Date	Aug 1, 2025

About Marinus Pharmaceuticals

AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. The company’s EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c ...

• Industry: Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products
• Founded: 1930
• Employees: 21,500
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1AME

Financial Performance

In 2024, AMETEK's revenue was $6.94 billion, an increase of 5.22% compared to the previous year's $6.60 billion. Earnings were $1.38 billion, an increase of 4.79%.